By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
A sensor is an apparatus that generates an output signal to sense a physical occurrence. A sensor is, in the broadest sense, a device, module, machine, or subsystem that recognises events or changes in its surroundings and transmits the data to other electronics, typically a computer processor. Always utilise sensors in conjunction with other electronics.
Sensors are employed in several applications that most people are unaware of, such touch-sensitive lift buttons (a tactile sensor) and lamps that can be dimmed or brightened by touching the base. The uses of sensors have grown beyond the conventional disciplines of temperature, pressure , and flow measurement, for example, into MARG sensors, thanks to advancements in micro machinery and user-friendly microcontroller platforms.
A new method for creating implantable sensors for glucose and other metabolites is called an affinity sensor.
These plans entail tagging the antibody or antigen with a species that can be detected or that may produce a species that can be detected. Enzymes, fluorescent, and electrochemical species are a few examples of labels.
The Global Affinity Sensor Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
Affinity sensor: a new technique for developing implantable sensors for glucose and other metabolites. Optical affinity sensors for detecting different compounds in blood plasma. The detection principle is similar to that employed in radioimmunoassays in that it is based on the competitive binding of a specific metabolite and a fluorescein-labelled analogue with receptor sites specific for the metabolite and the labelled ligand.
This principle has been applied to the construction of a glucose affinity sensor. Concanavalin A, a protein with unique glucose binding properties, was immobilised to the inner surface of a hollow dialysis fibre.
Optical affinity sensors for detecting different compounds in blood plasma. The detection principle is similar to that employed in radioimmunoassays in that it is based on the competitive binding of a specific metabolite and a fluorescein-labelled analogue with receptor sites specific for the metabolite and the labelled ligand.
